Crystal structure of human ATAD2 bromodomain in complex with N-(4- chloro-3-(N,N-DIMETHYLSULFAMOYL)PHENYL)-2-(2,5-dioxo-3',4'-dihydro- 2'H-SPIRO[IMIDAZOLIDINE-4,1'-naphthalen]-1-YL)ACETAMIDE

Structure

x-ray diffraction · 1 distinct chain · 75% helix, 0% strand (DSSP).

Ligands and binding sites

• KVZ · 2-[(4~{R})-2',5'-bis(oxidanylidene)spiro[2,3-dihydro-1~{H}-naphthalene-4,4'-imidazolidine]-1'-yl]-~{N}-[4-chloranyl-3-(dimethylsulfamoyl)phenyl]ethanamide · ligand · chains A
• SO4 · Sulfate ion · ion · 2 copies · chains A
• EDO · 1,2-ethanediol · additive · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

Compared structures

• 6S56 · Crystal structure of human ATAD2 bromodomain in complex with… · the same entry in another collection · chain A against A, TM-score 1.00
• Q6PL18 · AlphaFold monomer V2.0 prediction for ATPase family aaa domain- containing protein 2… · a predicted model of the same protein · chain A against A, TM-score 0.97

Analyse

• Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
• Every structure of UniProt Q6PL18
• Elsewhere: RCSB PDB 6S56 · PDBe 6S56 · UniProt Q6PL18